CEMQ:F:F-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.634

Change

+0.18 (+1.74)%

Market Cap

USD 0.46B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+16.20 (+3.13%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.56 (+1.12%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.64 (+1.16%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.29%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.70 (+1.65%)

USD 45.80B
0ZC:F Zscaler Inc

+9.68 (+4.99%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.37%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+4.16 (+3.48%)

USD 24.77B

ETFs Containing CEMQ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.22% 78% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.22% 78% C+ 70% C-
Trailing 12 Months  
Capital Gain 5.02% 62% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.02% 60% D- 54% F
Trailing 5 Years  
Capital Gain 64.13% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.13% 65% D 50% F
Average Annual (5 Year Horizon)  
Capital Gain 10.19% 70% C- 66% D+
Dividend Return 10.19% 68% D+ 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.37% 54% F 86% B+
Risk Adjusted Return 82.36% 81% B- 85% B
Market Capitalization 0.46B 59% D- 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike